NCT02516267View on ClinicalTrials.gov

Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.

NACompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

January 31, 2019

Conditions

Bleeding

Interventions

DEVICE

Multiplate ADP®

Patients will be evaluated by platelet function testing (Multiplate ADP®) daily until the value obtained\> 46 AU, when they will be immediately released to CABG

Trial Locations (1)

05409002

Carlos Alberto Kenji Nakashima, São Paulo

All Listed Sponsors

lead

University of Sao Paulo General Hospital

OTHER

NCT02516267 - Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT. | Biotech Hunter | Biotech Hunter